Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) EV-to-Revenue : -5.92 (As of May. 12, 2024)

Biodexa Pharmaceuticals EV-to-Revenue Chart

Biodexa Pharmaceuticals Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					12.33	27.49	15.02	0.40	2.07

Biodexa Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															15.02	-	0.40	-	-

Competitive Comparison of Biodexa Pharmaceuticals's EV-to-Revenue

For the Biotechnology subindustry, Biodexa Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biodexa Pharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biodexa Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biodexa Pharmaceuticals's EV-to-Revenue falls into.

Biodexa Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biodexa Pharmaceuticals's EV-to-Revenue for today is calculated as:

Biodexa Pharmaceuticals's current Enterprise Value is $-2.85 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biodexa Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodexa Pharmaceuticals  (NAS:BDRX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biodexa Pharmaceuticals's PS Ratiofor today is calculated as:

Biodexa Pharmaceuticals's share price for today is $0.9249.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $31.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodexa Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description